胰岛素抵抗对非酒精性脂肪肝发生的机理探讨
摘要
关键词
全文:
PDF镜像
|参考
development of nonalcoholic steatohepatitis:pathophysiology and clinical implications[J].Gastroenterology,2012(4):711-725. [2]Danaei G,Finucane MM,Lin JK,et al.National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants[J].Lancet,2011,377(9765):568-577. [3]Williams R.Global challenges in liver disease[J].Hepatology,2006,44(3):521-526. [4]Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association[J].Hepatology,2012,55(6):2005-2023. [5]Angulo P.Nonalcoholic fatty liver disease[J].N Engl J Med,2002,346(16):1221-1231. [6]Perry RJ,Kim T,Zhang XM,et al.Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler[J].Cell Metab,2013,18(5):740-748. [7]American Liver Foundation-Education Resources [Internet[J].cited,2015(11):89. [8]China Health and Nutrition Survey — China Health and Nutrition Survey (CHNS) [Internet][J].[cited,2015(11):101. [9]Liu S,Yeh TH,Singh VP,et al.β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice[J].Hepatology,2012,55(3):931-940. [10]曹颖,谢雯.非酒精性脂肪性肝病发病机制研究进展与现状[J].世界华人消化杂志,2017,25(8):670-683. [11]Wu H,Ng R,Chen X,Steer CJ,Song G.MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway[J].Gut,2016,65(11):1850-1860. [12]Janevski M, Ratnayake S, Siljanovski S, McGlynn MA, Cameron-Smith D, Lewandowski P. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat[J].Food Funct,2012,3(2):141-149. [13]Benhamed F,Denechaud PD,Lemoine M,et al.The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans[J].J Clin Invest,2012,122(6):2176-2194. [14]尹定子,宋海云.Wnt信号通路:调控机理和生物学意义[J].中国细胞生物学学报,2011,33(02):103-111. [15]Saravani R,Galavi HR, Noorzehi N, Ranjbar N, Mollashahee-Kohkan F. Common Variations in Perilipin rs1052700 and FTO rs3751812 Gene Variants, and Risk for Obesity and Type-2 Diabetes[J].Rep Biochem Mol Biol,2017,6(1):80-87. [16]Monga SP.β-Catenin Signaling and Roles in Liver Homeostasis Injury and Tumorigenesis[J].Gastroenterology,2015(7):1294-1310. [17]Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease[J].J Clin Invest,2005,115(5):1343-1351. [18]Liu H, Fergusson MM, Wu JJ, et al. Wnt signaling regulates hepatic metabolism[J].Sci Signal,2011,4(158):58. [19]Liu F,Song Y,Liu D.Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA[J].Gene Ther,1999,6(7):1258-1266. [20]颜少华,朱常琰,沈俊杰,高德化,张洪旭,韩思奕,游咏.VitD调控Wnt信号通路影响糖尿病心血管并发症的研究进展[J].生命的化学,2019,4(7):10. [21]陈峰,何生松,吴梅梅,等.不同转染方式对GFP表达质粒在小鼠肝脏的表达影响-中国学术期刊网络出版总库[J].山东大学学报(医学版),2010(01):17-20. [22]徐丽萍,马宁芳.Wnt/β-catenin信号通路与肝脏的发育及异常分化[J].解剖科学进展,2009,15(01):116-119. [23]Jiang J, Yamato E, Miyazaki J. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression[J].Biochem Biophys Res Commun,2001,289(5):1088-1092. [24]代雪枫,陈东风.非酒精性脂肪肝再生信号转导异常的研究进展[J].第三军医大学包,2019,22(27):2295-7. [25]董爽,吴晨明,胡君伟,等.Wnt5a对人肝星状细胞促炎细胞因子IL-1β及IL-6表达的影响[J].中华微生物学和免疫学杂志,2014,34(1):332-445. [26]Mani A,Radhakrishnan J,Wang H, et al.LRP6 mutation in a family with early coronary disease and metabolic risk factors [published correction appears in Science2013 Aug 30;341(6149):959][J].Science,2007(5816):1278-1282. [27]Van Camp JK,Zegers D,Verhulst SL,et al. Mutation analysis of WNT10B in obese children,adolescents and adults[J].Endocrine,2013,44(1):107-113. [28]Bell LN,Wang J,Muralidharan S,et al.Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study[J].Hepatology,2012,56(4):1311-1318.
Refbacks
- 当前没有refback。

